Skip to main content

BIOS Fund II, LP

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists BIOS Fund II, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ACTU Actuate Therapeutics, Inc.

Director, 10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 30, 2025 (view filing)1:02 PM ETJun 273 daysBIOS Fund I, LP and 9 othersDirector, 10% OwnerPPurchase+71.4K$7.00+$500.0K+57.1%196.4K afterDuplicate filing
Jun 30, 2025 (view filing)1:02 PM ETJun 273 daysBIOS Fund I, LP and 9 othersDirector, 10% OwnerPPurchase+71.4K$0.00$0–71.4K afterDerivativeDuplicate filing
Aug 20, 2024 (view filing)8:45 PM ETAug 146 daysBIOS Fund I, LP and 9 othersDirector, 10% OwnerSSale−25.0K$8.00−$200.0K−16.0%131.2K afterAmended3 lots
Aug 14, 2024 (view filing)8:44 PM ETAug 14Same dayBIOS Fund I, LP and 9 othersDirector, 10% OwnerPPurchase+500.0K$8.00+$4.00MNew position125.0K after2 lots
Aug 14, 2024 (view filing)8:44 PM ETAug 14Same dayBIOS Fund I, LP and 9 othersDirector, 10% OwnerSSale−25.0K$9.00−$225.0K−16.0%131.2K after3 lots

LTRN Lantern Pharma Inc.

10% Owner9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 13, 2025 (view filing)7:57 PM ETJun 13Same dayBIOS Fund I, LP and 9 others10% OwnerSSale−40.0K$3.09−$123.6K−25.9%114.3K after5 lotsDuplicate filing
Jun 13, 2025 (view filing)6:06 AM ETJun 10-123 daysLateBIOS Fund I, LP and 9 others10% OwnerSSale−61.6K$3.38−$208.3K−34.2%118.6K after15 lotsDuplicate filing
May 29, 2025 (view filing)9:55 PM ETMay 27-292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−56.2K$2.99−$168.4K−31.0%125.3K after15 lotsDuplicate filing
May 28, 2024 (view filing)4:30 PM ETMay 23-245 daysBIOS Fund I, LP and 9 others10% OwnerSSale−30.0K$6.30−$189.1K−18.6%131.5K after6 lots
Feb 29, 2024 (view filing)9:54 PM ETFeb 27-292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−144.0K$4.70−$676.3K−51.1%137.8K after9 lotsDuplicate filing
Jan 19, 2024 (view filing)4:31 PM ETJan 172 daysBIOS Fund I, LP and 9 others10% OwnerSSale−58.9K$4.20−$247.3K−25.9%168.4K after3 lotsDuplicate filing
Dec 1, 2023 (view filing)6:01 AM ETNov 292 daysBIOS Fund I, LP and 9 others10% OwnerSSale−145.3K$3.44−$500.0K−28.1%371.9K after2 lotsDuplicate filing
Nov 9, 2022 (view filing)9:37 PM ETNov 81 dayBIOS Fund I, LP and 9 others10% OwnerSSale−350.0K$4.40−$1.54M−68.1%164.1K after5 lots
Sep 7, 2022 (view filing)4:55 PM ETSep 25 daysBIOS Fund I, LP and 9 others10% OwnerSSale−6.45K$5.20−$33.5K−19.8%26.1K after2 lotsDuplicate filing

INAB IN8BIO, Inc.

10% Owner9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 7, 2025 (view filing)9:48 PM ETMay 25 daysLateBIOS Fund II, LP and 8 others10% OwnerPPurchase+1.15M–––2.43M afterDerivativeDuplicate filing
Oct 11, 2024 (view filing)6:12 PM ETOct 47 daysLateBIOS Fund II, LP and 8 others10% OwnerPPurchase+1.28M–––709.0K afterDerivative2 lots
Dec 14, 2023 (view filing)6:00 AM ETDec 131 dayBIOS Fund II, LP and 9 others10% OwnerPPurchase+1.72M–––574.2K afterDerivative3 lots
Dec 13, 2022 (view filing)7:00 AM ETDec 121 dayBIOS Fund II, LP and 9 othersDirector, 10% OwnerPPurchase+75.0K$2.48+$185.9K+15.1%570.7K after3 lots
Sep 29, 2022 (view filing)6:14 AM ETSep 281 dayBIOS Fund II, LP and 9 othersDirector, 10% OwnerPPurchase+25.0K$2.02+$50.5K+4.7%562.0K after3 lotsDuplicate filing
Aug 30, 2022 (view filing)1:16 PM ETAug 26-294 daysBIOS Fund II, LP and 8 othersDirector, 10% OwnerPPurchase+51.2K$2.02+$103.3K+10.1%559.1K after6 lotsDuplicate filing
Aug 30, 2022 (view filing)8:10 AM ETAug 26-294 daysBIOS Fund II, LP and 8 othersDirector, 10% OwnerPPurchase+51.2K$2.02+$103.3K+10.1%559.1K after6 lots
Aug 18, 2022 (view filing)8:00 PM ETAug 171 dayBIOS Fund II, LP and 8 othersDirector, 10% OwnerPPurchase+50.0K$1.93+$96.5K+9.9%553.1K after3 lotsDuplicate filing
Aug 17, 2022 (view filing)10:27 AM ETAug 161 dayBIOS Fund II, LP and 8 othersDirector, 10% OwnerPPurchase+1.77M$1.90+$3.37MNew position540.3K after3 lotsDuplicate filing

AZTR Azitra, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 23, 2023 (view filing)9:38 PM ETJun 212 daysBIOS Fund I, LP and 9 others10% OwnerSSaleConvertible Notes−669.3K––−100.0%0 after3 lotsDuplicate filing
Jun 23, 2023 (view filing)9:38 PM ETJun 212 daysBIOS Fund I, LP and 9 others10% OwnerPPurchase+2.30M$5.00+$3.00MNew position282.2K after6 lotsDuplicate filing

CGTX Cognition Therapeutics Inc

Director, 10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 29, 2022 (view filing)7:02 AM ETNov 281 dayBIOS Memory SPV I, LP and 9 othersDirector, 10% OwnerPPurchase+16.1K$2.65+$42.6K+5.5%309.7K after3 lotsDuplicate filing
Nov 17, 2022 (view filing)7:00 AM ETNov 161 dayFletcher Aaron G.L. and 9 othersDirectorPPurchase+71.0K$1.40+$99.4K+30.0%307.9K after3 lotsDuplicate filing
Nov 16, 2022 (view filing)7:00 AM ETNov 151 dayFletcher Aaron G.L. and 9 othersDirectorPPurchase+1.50M$1.20+$1.80MNew position299.6K after3 lotsDuplicate filing